Glenn Meden, MD

440.312.7140

Glenn Meden, MD

Appointed: 2009

Glenn Meden, MD
Department: Critical Care Medicine
Location: Hillcrest Hospital
Mail Code HC 323
6770 Mayfield Road
Mayfield Heights, OH 44124
WorkAppointment:440.312.7140
WorkFax:440.312.7142
Glenn Meden, MD
Department: Pulmonary Medicine
Location: Hillcrest Hospital
Mail Code HC 323
6770 Mayfield Road
Mayfield Heights, OH 44124
WorkAppointment:440.312.4500
DeskDesk:440.312.7140
WorkFax:440.312.7142
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Glenn Meden, MD, is the Chief of the Division of Pulmonary and Critical Care Medicine at Hillcrest Hospital, a position that he has held since 1996, and Director of the ICU at Hillcrest Hospital since 1995. He is board-certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine. Dr. Meden was appointed to the Cleveland Clinic Respiratory Institute in 2009.

Professional Highlights

  • American College of Chest Physicians (Fellow of the College of Chest Physicians, January, 1986)
  • The Society of Critical Care Medicine
  • American Thoracic Society

Education & Fellowships

Fellowship - Cleveland Clinic
Pulmonary Critical Care
Cleveland, OH USA
1984
Residency - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
1982
Medical School - The Ohio State University College of Medicine and Public Health
Columbus, OH USA
1979
Undergraduate - John Carroll University
University Heights, OH USA
1976

Certifications

  • Internal Medicine
  • Internal Medicine- Critical Care Medicine
  • Internal Medicine- Pulmonary Disease

Specialty Interests

Acute lung injury, asthma, bronchiectasis, bronchitis, chronic obstructive pulmonary disease (COPD), cough, emphysema, histoplasmosis, lung cancer, pneumonia

Awards & Honors

  • Outstanding Attending Teaching Award in Medicine, Huron Hospital, 1988

Treatment & Services

  • Treating Asthma With Bronchodilators

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Meden's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

Languages Spoken

  • English
Cleveland Clinic Mobile Site